A relentless disease calls for a relentless focus on helping patients and families.
PFIC clinical trials | committed to making a difference
The PEDFIC Program
Albireo is committed to advancing science and drug development with the goal of making a difference in the lives of those families affected by PFIC. As part of this commitment, Albireo is sponsoring the PEDFIC clinical trial program to evaluate a potential treatment for this disease.
To learn more about ongoing studies for patients living with cholestatic liver disease, please visit clinicaltrials.gov, or contact Albireo Medical Information (857.378.2035 or firstname.lastname@example.org) or complete the form below.
To receive PFIC updates and information, complete the form below. We’ll keep your entries confidential and only provide you with the requested information.